Nasus Pharma (NSRX) vs SCYNEXIS (SCYX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
SCYNEXIS (SCYX) has outperformed Nasus Pharma (NSRX) over the past year, losing 24.7% versus a loss of 47.6%. Nasus Pharma is the larger company by market cap ($42.5 million vs $42.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NSRX | SCYX |
|---|---|---|
| Share price | $3.63 | $4.22 |
| Market cap | $42.52M | $41.99M |
| 1-day change | -3.84% | -11.72% |
| YTD return | -58.74% | -5.46% |
| 1-year return | -47.64% | -24.65% |
| 5-year return | — | -89.27% |
| EPS (TTM) | $-1.20 | $-0.89 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.50 | $9.12 |
| 52-week low | $1.98 | $3.53 |
| Distance from 52-week high | -61.79% | -53.73% |
| Average volume | 16.09K | 274.80K |
| Shares outstanding | 11.71M | 9.95M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SCYX has outperformed NSRX by 23.0 percentage points over the past year.
NSRX vs SCYX FAQ
Which is bigger, Nasus Pharma or SCYNEXIS?
Nasus Pharma (NSRX) is larger, with a market capitalization of $42.52M compared with $41.99M for SCYNEXIS (SCYX).
Which stock has performed better over the past year, NSRX or SCYX?
SCYX returned -24.65% over the past 12 months, compared with -47.64% for NSRX (price return, excluding dividends). Past performance does not predict future results.
Are Nasus Pharma and SCYNEXIS in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.